Roche has been urged to honour the promise it made almost three years ago to make key Tamiflu trial data available for independent scrutiny. This latest correspondence is posted online as part of the iBMJ/i's open data campaign. Last week, Donald MacLean, Life Cycle Leader for Tamiflu, wrote to Professor Chris Del Mar in his capacity as coordinating editor of the Cochrane Acute Respiratory Infections Group, concerning "our debate on Tamiflu data." The ...
via Medindia Health News More READ
No comments:
Post a Comment